
Dental Bone Graft Substitutes Market Report 2026
Global Outlook – By Type (Xenograft, Allograft, Autograft, Other Types), By Material (Hydroxyapatite, Tricalcium Phosphate, Calcium Phosphate, Other Materials), By Mechanism (Osteoconduction, Osteoinduction, Osteogenesis, Osteopromotion), By Application (Ridge Augmentation, Sinus Lift, Socket Preservation, Periodontal Defect), By End-User (Hospitals, Dental Clinics, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Dental Bone Graft Substitutes Market Overview
• Dental Bone Graft Substitutes market size has reached to $4.41 billion in 2025 • Expected to grow to $5.76 billion in 2030 at a compound annual growth rate (CAGR) of 5.5% • Growth Driver: Rising Dental Disorders Fueling Growth In The Dental Bone Graft Substitute Market • Market Trend: Innovative Dental Bone Graft Substitutes Revolutionizing Oral Healthcare • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Dental Bone Graft Substitutes Market?
Dental bone graft substitutes refer to biocompatible substances used in oral and maxillofacial surgery to promote bone regeneration and restore lost or damaged bone tissue in the jaw or oral cavity. These materials are employed when a patient lacks sufficient natural bone volume or density, often due to tooth extraction, periodontal disease, trauma, or other dental conditions. The main types of dental bone graft substitutes are xenograft, allograft, autograft, and others. A xenograft dental bone graft substitute refers to various bone graft materials. These are made of multiple materials, such as hydroxyapatite, tricalcium phosphate, calcium phosphate, and others based on various mechanisms such as osteoconduction, osteoinduction, osteogenesis, and osteopromotion, and are used in ridge augmentation, sinus lift, socket preservation, and periodontal defects by hospitals, dental clinics, and other end users.
What Is The Dental Bone Graft Substitutes Market Size and Share 2026?
The dental bone graft substitutes market size has grown strongly in recent years. It will grow from $4.41 billion in 2025 to $4.65 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing prevalence of periodontal disease, growth in dental implant procedures, advancements in biomaterial science, expansion of oral surgery practices, improved patient awareness of restorative options.What Is The Dental Bone Graft Substitutes Market Growth Forecast?
The dental bone graft substitutes market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing demand for bioengineered graft materials, rising focus on minimally invasive grafting techniques, expansion of regenerative dental therapies, growing adoption of guided bone regeneration, increasing investment in advanced biomaterials. Major trends in the forecast period include increasing adoption of synthetic bone graft materials, rising demand for implant-supported procedures, growing use of osteoconductive biomaterials, expansion of regenerative dentistry applications, enhanced focus on faster bone healing.Global Dental Bone Graft Substitutes Market Segmentation
1) By Type: Xenograft, Allograft, Autograft, Other Types 2) By Material: Hydroxyapatite, Tricalcium Phosphate, Calcium Phosphate, Other Materials 3) By Mechanism: Osteoconduction, Osteoinduction, Osteogenesis, Osteopromotion 4) By Application: Ridge Augmentation, Sinus Lift, Socket Preservation, Periodontal Defect 5) By End-User: Hospitals, Dental Clinics, Other End Users Subsegments: 1) By Xenograft: Bovine-derived Xenograft, Porcine-derived Xenograft 2) By Allograft: Fresh Frozen Allograft, Freeze-Dried Allograft 3) By Autograft: Bone Marrow Aspirate, Cortical Bone Graft, Cancellous Bone Graft 4) By Other Types: Synthetic Bone Grafts, Composite Bone GraftsWhat Is The Driver Of The Dental Bone Graft Substitutes Market?
The increasing prevalence of dental disorders is expected to propel the growth of the dental bone graft substitute market going forward. Dental disorders refer to a group of medical conditions and health issues that specifically affect the oral cavity, which includes the teeth, gums, tongue, lips, cheeks, palate, and other structures within the mouth. Dental bone graft substitutes are used to treat dental disorders to address bone deficiencies in the jaw or to support dental implant placement that involves transplanting bone tissue to the affected area to provide a structure for new bone growth. For instance, in August 2024, according to the The Conversation U.S., a US-based publication company, the share of the UK population affected by gum disease is expected to rise from 42% today to 54% by 2050. Therefore, the increasing prevalence of dental disorders is driving the growth of the dental bone graft substitute industry.Key Players In The Global Dental Bone Graft Substitutes Market
Major companies operating in the dental bone graft substitutes market are Johnson and Johnson Services Inc., Zimmer Biomet Holdings Inc., Dentsply Sirona, Straumann Group, ZimVie Inc., LifeNet Health, RTI Surgicals Inc., Dentium Co. Ltd., BioHorizons Inc., Keystone Dental Inc., Geistlich Pharma AG, MIS Implants Technologies Ltd., Collagen Matrix Inc., Salvin Dental Specialties Inc., Osteogenics Biomedical Inc., Botiss biomaterials GmbH, Curasan Inc., Novabone Products LLC, Biomatlante S.A, Carmell Therapeutics Corp., Neobiotech Co. Ltd., Silfradent S.r.l.Global Dental Bone Graft Substitutes Market Trends and Insights
Major companies operating in the dental bone graft substitute market are developing innovative products such as regenerOss CC allograft particulate and regenerOss bone graft plug to provide reliable services to customers. RegenerOss CC allograft particulate is a dental bone graft substitute material with a natural blend of cortical and cancellous bone particles to promote bone regeneration in the oral cavity, and RegenerOss bone graft plug is a dental bone grafting solution to fill extraction sockets and periodontal defects. For instance, in April 2023, ZimVie Inc., a US-based medical instrument manufacturing company, launched RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug, a minimally invasive procedure that can be performed in an office setting. They are also relatively quick and easy to complete, with a short recovery time, and they are made from bovine bone, a biocompatible and osteoconductive material. These bone graft materials offer a safe and effective way to repair or reconstruct the jaw, and they can be used in various dental applications.What Are Latest Mergers And Acquisitions In The Dental Bone Graft Substitutes Market?
In April 2024, Geistlich Pharma India Pvt. Ltd., a Switzerland-based dental biomaterials company, acquired Bionnovation Biomedical, a Brazil-based company, for an undisclosed amount. With this acquisition, Geistlich aims to strengthen its capabilities in regenerative dentistry and dental bone graft substitutes, focusing on providing advanced solutions for periodontists, oral surgeons, and implant dentistry clinicians. Bionnovation Biomedical LTDA specializes in developing innovative biomaterials for bone regeneration in dental applications.Regional Outlook
North America was the largest region in the dental bone graft substitutes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Dental Bone Graft Substitutes Market?
The dental bone graft substitutes market consists of sales of demineralized bone matrix (DBM), ceramic-based bone grafts, calcium sulfate bone grafts, and synthetic bone graft substitutes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Dental Bone Graft Substitutes Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.65 billion |
| Revenue Forecast In 2035 | $5.76 billion |
| Growth Rate | CAGR of 5.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Material, Mechanism, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Johnson and Johnson Services Inc., Zimmer Biomet Holdings Inc., Dentsply Sirona, Straumann Group, ZimVie Inc., LifeNet Health, RTI Surgicals Inc., Dentium Co. Ltd., BioHorizons Inc., Keystone Dental Inc., Geistlich Pharma AG, MIS Implants Technologies Ltd., Collagen Matrix Inc., Salvin Dental Specialties Inc., Osteogenics Biomedical Inc., Botiss biomaterials GmbH, Curasan Inc., Novabone Products LLC, Biomatlante S.A, Carmell Therapeutics Corp., Neobiotech Co. Ltd., Silfradent S.r.l. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
